ACTRN12615000304538已完成1 期
A pharmacokinetic and safety study of the Chrono Nicotine Replacement Therapy System in male smokers.
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 12
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 50 Years（—）
- 性别
- Male
入选标准
- 未提供
排除标准
- •consume more than 2 alcoholic beverages a day
- •skin tattoos
研究者
相似试验
尚未招募
Unknown
Clinical trial on Standardized Crocus sativus Extract in Human VolunteersCTRI/2023/07/055436Pharmanza Herbal Pvt. Ltd
尚未招募
不适用
Study of Ranolazine table In-Vivo Bioequivalence in healthy volunteersIn this study, the disease is not examined. Subject bioequivalence test and reference tablets Ranolase studied..IRCT20200105046010N13Arena life science24
已完成
不适用
The clinical trial for safety and efficacy of chronic hepatitis therapeutics agent, 3-oxygelmillpropionic acid polymer for pancreatic cancer (Phase 1)Resectable pancreatic cancerJPRN-UMIN000027441Osaka University10
进行中（未招募）
1 期
Safety, Efficacy and Pharmacokinetics of NNC-0156-0000-0009 (N9-GP) in Previously Treated Children withHaemophilia BHaemophilia BMedDRA version: 14.1Level: LLTClassification code 10018939Term: Haemophilia B (Factor IX)System Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2011-000826-31-DEovo Nordisk24
已完成
3 期
Safety, Efficacy and Pharmacokinetics of NNC-0156-0000-0009 in Previously Treated Children with Haemophilia Bhaemophilia BJPRN-jRCT2080221833ovo Nordisk Pharma Ltd.40